Viking Therapeutics - Warrants (12/04/2021) (VKTX+) Q3 2021 Earnings

3NovConfirmed
Q4 2020
Q1 2021
Q2 2021
Q3 2021
-0.2
-0.18
-0.15
-0.13

Details

Expected EPS
-0.15
Actual EPS
-0.13
Surprise EPS
0.02
Surprise Percent
+13.33%

Description

Viking Therapeutics - Warrants (12/04/2021) (VKTX+) has reported earnings of -0.13 per share for Q3 2021.

0 Comments

Share your thoughts